AR014969A1 - Formulacion que contienen por lo menos una proteina tardia (proteina l) de uno o mas papilomavirus y/o por lo menos una proteina temprana (proteina e) deuno o mas papilomavirus, procedimiento para la preparacion de la formulacion mencionada asi como su utilizacion para la manufactura de un medicamen - Google Patents
Formulacion que contienen por lo menos una proteina tardia (proteina l) de uno o mas papilomavirus y/o por lo menos una proteina temprana (proteina e) deuno o mas papilomavirus, procedimiento para la preparacion de la formulacion mencionada asi como su utilizacion para la manufactura de un medicamenInfo
- Publication number
- AR014969A1 AR014969A1 ARP990101311A ARP990101311A AR014969A1 AR 014969 A1 AR014969 A1 AR 014969A1 AR P990101311 A ARP990101311 A AR P990101311A AR P990101311 A ARP990101311 A AR P990101311A AR 014969 A1 AR014969 A1 AR 014969A1
- Authority
- AR
- Argentina
- Prior art keywords
- protein
- papilomavirus
- formulation
- well
- procedure
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Formulacion que contiene por lo menos una proteína tardía (Proteína L) de uno o más papilomavirus y/o por lo menos una proteína temprana (Proteína E) deuno o más papilomavirus y de aproximadamente 0,3 a aproximadamente 4M, preferentementede aproximadamente 0,4 a aproximadamente 2,5 a 3M, en especialde aproximadamente 0,4 - 0,5 a aproximadamente 1 - 2M, en particular de aproximadamente 7,3 a 7,45, preferentemente igual a 7,4, como eventualmentetambién las adecuadas sustanciasaditivas y/o auxiliares, adecuadas; procedimiento para la preparacion de la formulacion mencionada así como suutilizacion para la manufactura de un medicamento o reactivo de diagnostico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19812940A DE19812940A1 (de) | 1998-03-24 | 1998-03-24 | Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR014969A1 true AR014969A1 (es) | 2001-04-11 |
Family
ID=7862147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990101311A AR014969A1 (es) | 1998-03-24 | 1999-03-24 | Formulacion que contienen por lo menos una proteina tardia (proteina l) de uno o mas papilomavirus y/o por lo menos una proteina temprana (proteina e) deuno o mas papilomavirus, procedimiento para la preparacion de la formulacion mencionada asi como su utilizacion para la manufactura de un medicamen |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1066321A2 (es) |
JP (1) | JP2002507625A (es) |
AR (1) | AR014969A1 (es) |
AU (1) | AU3598999A (es) |
CA (1) | CA2323526A1 (es) |
DE (1) | DE19812940A1 (es) |
MX (1) | MXPA00009283A (es) |
WO (1) | WO1999048917A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1355925A2 (en) * | 2000-12-08 | 2003-10-29 | Academisch Ziekenhuis Leiden | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
CA2431500C (en) | 2000-12-08 | 2016-06-07 | Sjoerd Hendrikus Van Der Burg | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
EP1213299A1 (en) * | 2000-12-08 | 2002-06-12 | Leids Universitair Medisch Centrum | Immunogenic epitopes of human papilloma virus and uses thereof |
US7901921B2 (en) * | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3915794A (en) * | 1973-02-09 | 1975-10-28 | Rit Rech Ind Therapeut | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
DE4447664C2 (de) * | 1994-10-07 | 1999-04-15 | Lutz Prof Dr Gissmann | Fusionsproteine, Verfahren zu deren Herstellung sowie deren Anwendung |
WO1996011272A2 (de) * | 1994-10-07 | 1996-04-18 | Medigene Gesellschaft Für Molekularbiologische Diagnostik, Theraphie Und Technologie Mbh | Papillomavirusähnliche partikel, fusionsproteine sowie verfahren zu deren herstellung |
-
1998
- 1998-03-24 DE DE19812940A patent/DE19812940A1/de not_active Withdrawn
-
1999
- 1999-03-24 CA CA002323526A patent/CA2323526A1/en not_active Abandoned
- 1999-03-24 WO PCT/EP1999/001999 patent/WO1999048917A2/de not_active Application Discontinuation
- 1999-03-24 MX MXPA00009283A patent/MXPA00009283A/es unknown
- 1999-03-24 EP EP99917850A patent/EP1066321A2/de not_active Withdrawn
- 1999-03-24 AU AU35989/99A patent/AU3598999A/en not_active Abandoned
- 1999-03-24 JP JP2000537899A patent/JP2002507625A/ja active Pending
- 1999-03-24 AR ARP990101311A patent/AR014969A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU3598999A (en) | 1999-10-18 |
JP2002507625A (ja) | 2002-03-12 |
MXPA00009283A (es) | 2002-12-13 |
WO1999048917A2 (de) | 1999-09-30 |
WO1999048917A3 (de) | 1999-12-09 |
DE19812940A1 (de) | 1999-10-07 |
CA2323526A1 (en) | 1999-09-30 |
EP1066321A2 (de) | 2001-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1033582A1 (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
ECSP055635A (es) | Agentes citotoxicos que contienen taxanos potentes novedosos y su uso terapeutico | |
AR034881A1 (es) | Mezcla insecticida | |
BRPI0111220B1 (pt) | conjugados de fármacos com etilenodicisteína (ec) | |
DE69941429D1 (de) | 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a | |
EA200100541A1 (ru) | Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов | |
IL127558A0 (en) | Hepatocyte growth factor receptor agonists and uses thereof | |
PT785948E (pt) | Analogos do factor de crescimento de queratinocitos | |
EE200000380A (et) | 11ß-halogeno-7(alfa)-asendatud östratrieenid, neid 11ß-halogeno-7(alfa)-asendatud östratrieene sisaldavate farmatseutiliste preparaatide valmistamise meetodid ja nende kasutamine ravimite valmistamiseks | |
ES2140565T3 (es) | Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos. | |
IS1565B (is) | Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar | |
DE69904922D1 (de) | Pharmazeutische zusammensetzung zur behandlung von alkoholabhängigkeit, die opioid antagonisten mit nmda-rezeptorkomplex-modulatoren enthält | |
ATE308328T1 (de) | Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen | |
MX9704050A (es) | P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n. | |
HUP0105134A2 (hu) | Szubsztituált 2-arilimino-heterociklusok és ilyen vegyületeket tartalmazó készítmények progeszteron receptorhoz kötődő szerekként való alkalmazásra | |
TR200101970T2 (tr) | Solunum yollarì hastalìklarìnìn tedavisinde matriks metaloproteaz inhibitrleri olarak ikameli 4-biarilbutirik ve 5-biarilpentanoik asit trevlerinin kullanìlmasì | |
IL139318A0 (en) | Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same | |
DE69527366D1 (de) | Enzymatische zusammensetzung fur die klinische untersuchung | |
DE69133077D1 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
AR014969A1 (es) | Formulacion que contienen por lo menos una proteina tardia (proteina l) de uno o mas papilomavirus y/o por lo menos una proteina temprana (proteina e) deuno o mas papilomavirus, procedimiento para la preparacion de la formulacion mencionada asi como su utilizacion para la manufactura de un medicamen | |
AR004093A1 (es) | El uso de una proteina derivada de una quimioquina de mamifero y un medicamento util para movilizar celulas tronco hematopoyeticas. | |
AR020832A1 (es) | Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5-(10)-en-20-in-3-ona | |
ES2129893T3 (es) | Dinucleosido-5',5'-pirofosfatos. | |
ES2140672T3 (es) | Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos. | |
DE69711588D1 (de) | Nimesulid enthaltende pharmazeutische zubereitung zur topischen anwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |